ArticleJournal of pain and symptom management2008

Intravenous ibandronate rapidly reduces pain, neurochemical indices of central sensitization, tumor burden, and skeletal destruction in a mouse model of bone cancer.

Kyle G Halvorson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.